Exploring Diagnostic and Therapeutic Markers Based on Immune-Related
Genes in Psoriasis
Abstract
Background: Psoriasis is a recurrent chronic skin inflammatory disease.
Its biomarkers are currently inaccurate and lack specificity. Hence, the
immune infiltration mechanism of the key differential genes in psoriasis
and related principles are discussed in this article. Methods: The
GSE30999, GSE67853 and GSE78097 data sets were downloaded from the Gene
Expression Omnibus(GEO) database, and the differentially expressed genes
were screened with p<0.05 & |Log2FC|>1 by R
language. Then, hub genes were picked out through LASSO and BORUTA
analyses and verified in exterior dataset GSE83582. Further, we used
ssGSEA to evaluate the effect of genes on immune infiltration. GSVA and
GSEA algorithms were applied to assess associations between hub genes
and different pathways for enrichment. Finally, the gene selection model
of psoriasis-based immune infiltration will be examined by ROC. Results:
The characteristic genes of psoriasis are determined to be TMPRSS11D,
S100A12 and KYNU by the intersection of two algorithms. These three
genes all have strong correlations with the content of immune cells and
immune-related genes. Highly expressed TMPRSS11D, S100A12, and KYNU
genes are involved in HEME_METABOLISM, XENOBIOTIC_METABOLISM, and
MTORC1 pathways indicating that core genes affect the development and
progression of psoriasis by regulating metabolism and T cell-related
immunity. GESA showed that hub genes are linked to immune factors
concerning enriched pathways. The AUC values of these three core genes
are TMPRSS11D = AUC: 0.980 (0.959–1.000), S100A12= AUC: 0.982
(0.963–1.000), KYNU= AUC: 0.992 (0.982–1.000). Hub genes are actively
associated with each other. Eventually, the differential gene expression
of these key genes is validated by external datasets. Conclusion:
Combining bioinformatics to analyze the immune infiltration mechanism of
psoriasis provides a basis for discovering novel diagnostic biomarkers.